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L

ittle has been done to provide
guidelines for the optimal care
of human immunodeficiency
virus (HIV)-exposed, but uninfected, infants to help them to reach
their full potential. Data from the
Centers for Disease Control and
Prevention (CDC) (2018) show that
approximately 8,500 women living
with HIV give birth annually in the
United States, and only a small proportion of their babies are born with
perinatal diagnoses of HIV. In 2016,
only 99 infants were born with perinatal diagnoses of HIV (CDC, 2018).
However, those HIV-free children who
are born to women with HIV require
special care to address their risk for
postnatal HIV infection. They need
nutritional support, timely vaccinations, and screenings for infectious
diseases, such as group B streptococcus, pertussis, tuberculosis, and Pneumocystis carinii pneumonia. Families of
HIV-exposed but uninfected infants
also need special support, accurate
medical information, and anticipatory
guidance to help them prevent the
transmission of HIV to their infants
while ensuring proper bonding and
care (Robinson & Fernandez, 2010).
Currently, most healthcare providers who interact with HIV-exposed
infants and their families have limited
knowledge about how those families
are caring for their infants because
they do not interact with them on a
routine basis (Robinson & Fernandex,
2010). As a result, there is often a significant gap in care (Robinson &
Fernandez, 2010). This article aims to
help by providing comprehensive
information to pediatric nurses and
nurse practitioners who care for HIVexposed uninfected children.

Shweta P. David, BSN, RN, is a Registered
Nurse, the Mitocondrial Center, the Children’s
Hospital of Philadelphia Philadelphia, PA.

The care of infants born to human immunodeficiency virus (HIV)-infected mothers is unique and often challenging to healthcare providers. The progress in HIV
treatment, care, and support in past years, particularly in prevention programs
aimed at eliminating mother-to-child transmission, resulted in a significant number of children who were exposed to HIV in utero being born HIV-free. However,
children born to HIV-infected mothers are considered vulnerable whether they
are born with HIV or not. They require diligent healthcare follow up because
exposure to HIV can have a negative impact on their growth and development.
One of the most important goals for healthcare providers is to help these children
attain a good quality of life by providing appropriate postnatal care in a timely
manner. Primary care should include antiretroviral (ARV) therapy, identification of
risks for HIV infection, optimization of growth and development, administration of
immunizations, and screening for infectious diseases. Anticipatory guidance for
the HIV-exposed child is also important. Primary care pediatric nurses and nurse
practitioners require a good understanding of the needs of uninfected-HIV infants
who were exposed to HIV in utero and education for their families.

General Guidelines for Care
During Office Visits
The World Health Organization
(WHO) and the United Nations
Children’s Fund (UNICEF) recommend that an HIV-exposed infant
should be followed up within 14 days
after birth, and then monthly with
their primary care provider (Siberry,
2014). A full reassessment should be
done at each primary care follow-up
visit to check for growth issues, such
as retardation and neuro-developmental issues, as well as other physical
findings that may indicate the infant
has HIV (Siberry, 2014). During the
visit, the practitioner should share
important information about minimizing HIV infection risk to the child,
conduct virological tests to detect HIV
infection, and counsel the mother
about her own status (WHO, 2008).
The visit also gives clinicians an
opportunity to assess the family’s need
for social support, review plans for
testing and results, and reiterate safe
feeding practices, such as formula
feeding instead of breastfeeding
(Siberry, 2014).
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Testing
Children younger than 18 months
require a virological assay to test for
HIV (Robinson & Fernandez, 2010).
Antibody testing cannot be used to
verify the infection status of an infant.
The reason is because the mother’s
HIV antibodies are transferred across
the placenta in the third trimester and
do not decay completely from the
bloodstream of some infants until
they reach 18 months of age
(Robinson & Fernandez, 2010). The
two most commonly used virological
tests in the United States are nucleic
acid amplification tests are 1) HIV-1
DNA polymerase chain reaction
(PCR), which detects cell-associate
proviral DNA, and 2) HIV-1 RNA PCR,
which detects plasma viral RNA
(Robinson & Fernandez, 2010). Both
assays have high sensitivity and specificity by the first 4 to 6 weeks of life
(Robinson & Fernandez, 2010). Babies
born to HIV-infected women are tested when they are 14 to 21 days old,
then at 1 to 2 months, and again at 4
to 6 months (Robinson & Fernandez,
2010). Results on both virologic tests
must be negative to confirm the
infant does not have HIV (U.S.
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Table 1.
Antiretroviral Drug Dose and Duration
ARV Drug and Dose

Duration

Zidovudine should be given to all HIV-exposed newborns and should be started as soon
after birth as possible, preferably within 6 to 12 hours of delivery.

Within 6 to 12 hours of delivery.

≥35 weeks gestation at birth: 4 mg/kg orally twice daily (if unable to tolerate oral agents,
3 mg/kg/dose intravenously, beginning within 6 to 12 hours of delivery, then every 12
hours).

Birth through 6 weeks.

≥30 to <35 weeks gestation at birth: 2 mg/kg orally (or 1.5 mg/kg intravenously) every 12
hours, advanced to 3 mg/kg orally (or 2.3 mg/kg intravenously) every 12 hours at age 15
days.

Birth through 6 weeks.

<30 weeks gestation at birth: 2 mg/kg orally (or 1.5 mg/kg intravenously) every 12 hours,
advanced to 3 mg/kg orally (or 2.3 mg/kg intravenously) every 12 hours after age 4
weeks.

Birth through 6 weeks.

Nevirapine administered in addition to zidovudine to newborns of HIV-infected women
who received no antepartum ART prophylaxis.

Given to newborns if no antepartum
ART prophylaxis is given.

Weight band dosing.

Three doses in the first week of life.

Birth weight 1.5 to 2 kg: 8 mg for each dose.

First dose within 48 hours of birth (as
soon after birth as possible).

Birth weight >2 kg: 12 mg for each dose.

Second dose 48 hours after first.
Third dose 96 hours after second.

Notes. ART = antiretroviral therapy; HIV = human immunodeficiency virus. Nevirapine dosing given as actual doses not as milligram
per kilogram dosing.
Source: Siberry (2014). Adapted from DHHS, 2017.

Department of Health and Human
Services [DHHS], 2017). The first negative result must be obtained when
the baby is 1 month or older, and the
second must be done at 4 months or
older. Two positive tests indicate the
infant has HIV (DHHS, 2017).

Prophylaxis
Multiple routes exist by which a
child can get an HIV infection. The
most common is mother-to-child transmission, which can happen during
pregnancy, childbirth, and via breastfeeding (Siberry, 2014). Antiretroviral
(ARV) drugs can effectively eliminate
the risk of mother-to-child transmission
during the course of pregnancy, and
they can also help improve maternal
survival (Barker & Mate, 2012).
According to the WHO, ARV treatment should be initiated as soon as
possible in HIV-exposed infants
(Horwood et al., 2009). If an infant is
suspected to have been exposed to the
virus postnatally, even when the virologic tests are negative, they should be
started on co-trimoxazole prophylactically at 2.5 to 5 mg/kg twice daily.
Antiretroviral theory (ART) prophylaxis
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and co-trimoxazole should be discontinued if virologic results prove absence
of the infection based on two negative
results performed no earlier than 2
months, and at least one performed no
earlier than 4 months (Siberry, 2014).
Table 1 describes the ARV drug, dose,
and duration of treatment.
Immunizations. Infants in the
United States who have been exposed
to HIV but are uninfected must be on
a routine vaccination schedule (Jones
et al., 2011). Infants born to HIVinfected mothers can have low levels
of passively transferred protective
maternal antibodies, and that puts
them at a higher risk for pneumococcal infection and other preventable
diseases (Jones et al., 2011). These
infants should be given vaccines for
hepatitis B, diphtheria, tetanus toxoids, acellular pertussis, inactivated
poliovirus, pneumococcal conjugate
13, Haemophilus influenzae type B, and
rotavirus (Robinson & Fernandez,
2010). Hepatitis B is a common coinfection in HIV-positive mothers,
and it can be transmitted from mother
to child during delivery. It is impossible to reduce this transmission to zero,

so in the United States, a birth dose of
the vaccine is provided, which has
reduced vertical transmission by 75%
(Chotun, Nel, Cotton, Preiser, &
Anderson, 2015).
Feeding. The WHO recommends
that HIV-positive women breastfeed
exclusively for the first six months of
the infant’s life, unless replacement
with formula feeding is acceptable,
feasible, affordable, sustainable, and
safe (Ngwende et al., 2013). Exclusive
breastfeeding does not irritate the
stomach lining like mixed feeds or
commercial milk products (Ngwende
et al., 2013). Breastfeeding carries
some risk for vertical transmission, but
breast milk is sufficient to meet the
nutritional needs of the infant under
the age of 6 months (Nabwera et al.,
2017). Unfortunately, HIV-infected
mothers in the United States are not
advised to breastfeed because maternal or infant ARV cannot totally eliminate HIV transmission via breast milk
(Siberry, 2014). Therefore, mothers
should be repeatedly counseled
against breastfeeding before delivery
and during the initial outpatient visits
(Siberry, 2014).
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Infections
Group B Streptococcus
Group B streptococcus causes
neonatal sepsis and is a cause of mortality worldwide. Studies from both
developing and developed countries
indicate that infants who are HIVexposed are at increased risk for group
B streptococcus (Dauby, Chamekh,
Melin, Slogrove, & Goetghebuer,
2016). Transmission of group B streptococcus from a colonized mother to
her newborn can occur vertically
before or during labor, or horizontally
during the neonatal period (Dauby et
al., 2016). These infants have higher
infection rates, particularly severe
cases, and require more hospitalizations (Dauby et al., 2016). Studies indicate there is a correlation between
advanced maternal HIV infection
when maternal CD4 count is lower
than 350 cells/mm3 and higher morbidity in HIV-exposed infants (Dauby
et al., 2016). In the HIV-exposed
infants, group B streptococcus typically presents with meningitis (Dauby et
al., 2016). The reasons for the
increased group B streptococcus risk in
these infants include a compromised
immune system, a neonatal gut
microbiome dysbiosis, and the mother’s inability to breastfeed. When an
HIV-positive mother does not breastfeed her infant, it hampers passive
protection of the neonate that occurs
through ingestion of group B streptococcus-specific IgA in breastmilk.
These altered infant feeding practices
are likely to have more effect on the
incidence of group B streptococcus
(Cools et al., 2017). New interventions, such as promoting breastfeeding or using probiotics and prebiotics,
can be used effectively to prevent
group B streptococcus (Cools et al.,
2017).

Pertussis
Pertussis has re-emerged in developed countries, and is prevalent in
low and middle-income countries
mainly due to the failure to recognize
the disease in HIV-exposed infants
who present with only the classic
paroxysmal coughing spells. Pertussis
is more common in HIV-exposed
infants, and rate of hospitalization is
higher in this population (Soofie et al.,
2016). These cases of pertussis typically occur by 3 months of age in an HIVexposed infant due to low transplacental maternal antibodies (Soofie et

al., 2016). The number of hospitalizations in 2014 in the United States was
similar to the number of hospitalizations worldwide in the HIV-exposed
infant younger than age 6 months
(Soofie et al., 2016). Vaccination of
both the infant and the mother can
reduce the risk of pertussis (Soofie et
al., 2016). Vaccination with acellular
pertussis during pregnancy is safe and
effective at protecting infants from
pertussis and reduces mortality in
infants too young to be vaccinated.
Use of a polymerase chain reaction
(PCR) test can help diagnose pertussis
in these infants (Soofie et al., 2016).
Tuberculosis.
As per the
American Academy of Pediatrics (AAP)
(1997), infants of HIV-infected
women may be at increased risk of
tuberculosis (TB) due to household
exposure of immune-compromised
individuals who are at risk for TB and
HIV infection. An HIV-positive mother should be checked for TB during
pregnancy, and the infant should be
checked before being discharged from
the nursery. Information about the TB
status of other household contacts
should be requested (AAP, 1997). If the
mother has hematogenous dissemination of TB, then the infant should be
checked for congenital TB (AAP, 1997).
If the mother or a household contact
has active TB pulmonary disease, then
the infant should be separated from
that person until the person is considered non-contagious (AAP, 1997). Any
infant or young child exposed to a
person with contagious TB should
undergo tuberculin skin testing and a
chest X-ray (AAP, 1997). Even if the
skin test is nonreactive and the chest
radiograph shows no abnormalities,
the infant should receive prophylaxis
with isoniazid for three months until
a skin test is repeated. If the skin test is
positive (5 or more millimeters of the
induration), antituberculous therapy
is continued (AAP, 1997). All HIVuninfected children who reside with
HIV-infected individuals should have
annual TB skin testing beginning at 1
year of age (AAP, 1997).
Pneumocystis carinii pneumonia. Pneumocystis carinii pneumonia
(PCP) is a common and often fatal
opportunistic infection in HIVexposed infants (Simonds, Oxtoby,
Caldwell, Gwinn, & Rogers, 1993).
PCP peaks at 3 to 6 months of age and
is rare in the first month of the infant’s
life (Simonds et al., 1993). Clinicians
should consider PCP if an HIVexposed infant presents with fever,
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dyspnea, progressive cough, and poor
feeding. Untreated infants can
become hypoxic, can develop respiratory failure, and can even die
(Simonds et al., 1993). Failure to recognize HIV exposure to start treatment in these infants has been a
prominent gap. These infants need to
be identified earlier to start chemoprophylaxis as per the recommended
guidelines (Simmonds et al., 1993).
Children who are HIV-positive may
present with mucosal candidiasis, oral
thrush, sinusitis otitis media, parotid
gland swelling, lymphadenopathy,
chronic interstitial lung disease, and
herpes zoster (Siberry, 2014). An HIVexposed child should be tested immediately for HIV if any of these conditions surface (Siberry, 2014).

Costs, Barriers, and Missed
Opportunities
Cost is a major constraint in many
low-resource countries that try to test
for early infant diagnosis (Dunning et
al., 2017), but not in the United States
because there are more resources available. The AAP recommends that physicians document three negative PCRs
by DNA followed by serologic reversion by enzyme-linked immunosorbent assay (ELISA) of children who are
exposed to HIV in utero (Benjamin et
al., 2001). The cost of diagnosing HIV
with the use of serologic follow up
given the high quality of PCR is also
unknown. The cost per child of conducting both an ELISA and a Western
blot test is approximately $351
(Benjamin et al., 2001). Diagnosis of
HIV during early infancy, followed by
prompt initiation of ARV therapy, dramatically reduces mortality.
There are also certain barriers to
care. For instance, a family may live in
a rural area, and find it difficult to travel to a clinic and wait for care, even in
the United States (Bonawitz et al.,
2016). It is very important that caregivers understand the child’s ARV treatment and adherence (Coulibalyet al.,
2016). Poor healthcare facilities, insufficient knowledge among heathcare
workers and caregivers, and bad attitudes among healthcare workers prevent families from getting timely care
for these infants (Coulibaly et al.,
2016). The inability to prevent HIV
transmission in the United States has
been linked with missed opportunities
to provide ARV to infected mothers
and late maternal diagnosis of HIV
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(Taylor et al., 2017). Other factors
include health disparities, missed testing opportunities, and inconsistencies
in the care of HIV-infected women in
early interventions that could optimize
the care of women and infants (Taylor
et al., 2017). Other barriers in the
United States include insurance concerns, low incomes, and inaccessibility
of care for many minorities. Some pregnant women go undiagnosed and do
not realize they are HIV positive. Other
women know their status and are taking medications, but their baby can still
be exposed to HIV, resulting from
missed follow ups, improper feeding,
and inaccessible services.

Nursing Implications
Nurses and nurse practitioners are
front-line providers who can educate
families and provide anticipatory
guidance that can help families seek
out the best care for the HIV-exposed
infants. Nurses should know the
extreme importance of recognizing
the early signs of HIV infection in an
infant and provide prompt treatment.
Nurses also need to know that prevention of HIV transmission in an HIVexposed infant should include appropriate ARV treatment, immunizations,
feeding, and regular check ups.
Prevention of HIV begins before the
baby is born, so providing appropriate
care for the HIV-infected mother and
infant is very important (Robinson &
Fernandez, 2010).
Nurses must educate families about
HIV testing. The HIV status of the
baby may remain unknown for several
months, so nurses should be prepared
to provide supportive care for families
who may have a great deal of anxiety
while they are waiting for this information. Each visit must include a discussion about the importance of giving the infant ARV drugs as prescribed.
HIV-positive mothers should be
advised to formula feed only and not
breastfeed (Robinson & Fernandez,
2010). HIV-exposed infants must
receive the same immunizations as
other infants (Robinson & Fernandez,
2010).
Mothers and caregivers should also
receive education on the modes of
HIV transmission. They should know
that HIV is not transmitted by touching, hugging, or kissing their infants
(Robinson & Fernandez, 2010).
Learning that your child is infected
with HIV can be emotionally devastating (Siberry, 2014). Clinicians can help
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by listening and offering emotional
support, in addition to providing reassurance that there are effective treatments that can help with quality of
life and survival in these infants
(Siberry, 2014).
Providers should know that some
HIV-infected women might be seriously ill, and have partners or other children who are ill, or have died because
of complications of AIDS (AAP, 1997).
They might be very poor, not have
healthcare coverage, or might fear losing their existing insurance coverage
(AAP, 1997). Other factors, such as
substance abuse, alcohol use, housing
insecurity, domestic violence, and
depression, should be screened, and
social services should be used to
enhance proper care of the infant as
well as the mother (AAP, 1997).
Often, a mother does not learn she
has HIV until her child comes to the
hospital and is diagnosed. This is particularly true when the child was
exposed or infected in utero. If the
child is tested and diagnosed as early
as possible in infancy, and if appropriate treatment is provided, they can
avoid seroconverting from HIVexposed to HIV-positive status. Applying these recommendations can guide
nurses and nurse practitioners who
diagnose and treat patients with HIV,
and help improve outcomes and quality of life in HIV-exposed infants.
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